<DOC>
	<DOCNO>NCT01367743</DOCNO>
	<brief_summary>The efficacy tolerability norepinephrine epinephrine cardiogenic shock reperfused myocardial infarction compare , follow cardiac index evolution main criterion . The study pilot pathophysiological study , randomize , double blind multicenter .</brief_summary>
	<brief_title>Study Comparing Efficacy Tolerability Epinephrine Norepinephrine Cardiogenic Shock</brief_title>
	<detailed_description>Cardiogenic shock secondary myocardial infarction frequent pathology reanimation associate high mortality ( 50 % ) . Hemodynamic management notably choice vasopressor cardiogenic shock state secondary myocardial infarction ( cardiac index &lt; 2.2 l/min/m-2 ) codify . There two opposite view : ) first base fact hypotensive patient low cardiac output primarily need inotropic agent , consequently , epinephrine molecule choice ( inotropic vasoconstrictor ) ; b ) second base fact hypotension also reflect certain degree vascular failure vascular vasoplegia therefore norepinephrine molecule choice along , need , eventual addition dobutamine order separately titrate vasoconstriction inotropism . Study hypotheses : epinephrine could facilitate myocardial function provide latter preferred substrate ( lactate ) thus induce high cardiac index along increase energy expenditure . Norepinephrine therapy choice hypotensive state ; nevertheless lack inotropic effect could theoretically exacerbate myocardial failure . Thus , aim study compare efficiency tolerability norepinephrine epinephrine cardiogenic shock reperfused myocardial infarction .</detailed_description>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Cardiogenic</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<criteria>man woman old 18 year cardiogenic shock due myocardial infarction treat angioplasty SAP &lt; 90 MM Hg MAP &lt; 65 mm Hg without vasopressor sign tissue hypoperfusion cardiac index &lt; 2.2 l/mn/m2 absence vasopressive inotropic therapy pulmonary artery occlusion pressure &gt; 15 mm Hg echocardiographic evidence high pressure ( mitral profile ) exclusion covert hypovolemia : Delta PP feasible &gt; 13 % ( patient adapt ventilator sinus rhythm ) /or response passive leg raise ejection fraction &lt; 40 % ultrasound without inotrope support . This criterion take account instance treatment dopamine , norepinephrine , epinephrine , dobutamine milrinone . shock origin immediate indication mechanical assistance device minor age patient patient write consent patient family obtain . Given seriousness medical situation time inclusion , patient consent difficult impossible obtain . The inclusion possible information provide consent obtain family member . As soon possible , protocol information issue patient order obtain consent continuance . cardiac arrest early sign cerebral anoxia . septic , toxic obstructive cardiomyopathy arrhythmogenic cardiomyopathy patient coronary insufficiency patient ventricular rhythm disorder patient treat medicine list contre indication patient without social assurance patient major legal protection safeguard justice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>epinephrine</keyword>
	<keyword>norepinephrine</keyword>
	<keyword>cardiac output</keyword>
</DOC>